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Introduction {#sec1}
============

*Saccharomyces cerevisiae* Tel1 and its highly conserved human ortholog ataxia-telangiectasia mutated (ATM), are major kinases responsible for maintaining genome integrity. Tel1^ATM^ is recruited to sites of DNA damage by the MRX/N complex, a key element in double-strand DNA (dsDNA) break repair comprising Mre11, Rad50, and Xrs2 (Nbs1 in human) ([@bib14]). MRX/N is also the major activator of Tel1^ATM^, which subsequently phosphorylates hundreds of targets that contain an S/T-Q motif ([@bib23], [@bib26], [@bib24], [@bib25], [@bib41]). Many of these targets, including CHK1/2, ATM, BRCA1, PALB2, p53, and H2AX, are tumor suppressors involved in cell-cycle control and dsDNA break repair through homologous recombination ([@bib22], [@bib26]). The precise mechanism of Tel1^ATM^ activation is not fully understood, but is suggested to involve autophosphorylation ([@bib20]), lysine acetylation ([@bib39]), and dissociation of homodimers into monomers ([@bib3]). Critically, mutations in ATM are found in ataxia-telangiectasia (A-T), a rare disease primarily associated with immunodeficiency and progressive neurological decline. A-T patients also have an increased susceptibility to malignancy due to genomic instability, and ATM is one of the most frequently mutated genes in many cancers ([@bib11]).

Tel1^ATM^ belongs to a family of phosphatidylinositol 3-kinase (PI3K)-like kinases that also includes ATR (ATM-Rad3-related, and its yeast ortholog Mec1), DNA-PKc, mammalian target of rapamycin (mTOR), TRRAP/Tra1, and SMG1 ([@bib6]). All PI3K kinases contain a canonical two-lobed kinase domain, with the smaller N-lobe containing the highly conserved glycine-rich loop (Gly-rich loop), while the larger C-lobe possesses the catalytic and activation loops ([@bib42]). A number of additional conserved and functional elements within the kinase domain have been identified in phosphatidylinositol 3-kinase-related kinases (PIKKs) including the LST8-binding element (LBE) ([@bib45]) and the PIKK regulatory domain (PRD) ([@bib28]). Flanking the kinase domain are the N-terminal HEAT repeats, followed by a FAT (FRAP \[FKBP12-rapamycin-associated protein\], ATM, TRRAP \[transformation/transcription domain-associated protein\]) domain and a ∼35-residue FATC domain at the C terminus ([@bib17]). Due to their large sizes, structural and mechanistic studies on these kinases have been challenging. A number of high-resolution structures (\<4.0 Å, where many side chains can be resolved) are available, mostly of those involving mTOR, including its complexes with a number of activator proteins ([@bib46]). The 4.3-Å crystal structure of DNA-PKcs revealed the architecture of this large PIKK ([@bib36]), whereas the 3.9-Å cryoelectron microscopy (cryo-EM) structure of Mec1-Ddc2 provided a structural basis for how ATR^Mec1^ might be kept in an inhibited state ([@bib43]). The cryo-EM structures of Tel1 ([@bib44]) and human ATM ([@bib7]) in the absence of nucleotides have shed some light into kinase function, but do not provide a complete understanding of the role of the regulatory elements in maintaining an auto-inhibited state.

Here we present the cryo-EM structure of *Saccharomyces cerevisiae* Tel1 in complex with an ATP analog, AMP-PNP, with sufficient resolution (3.7--3.9 Å) to resolve the bound nucleotide and allow most of the side chains in the conserved FAT-kinase-FATC (FAT-KIN) to be resolved ([Figures 1](#fig1){ref-type="fig"}, [S1](#mmc1){ref-type="supplementary-material"}, and [S2](#mmc1){ref-type="supplementary-material"} and [Table 1](#tbl1){ref-type="table"}). Significantly, a conserved insertion in the PRD-I obscures peptide substrate access to the active site. This explains the low intrinsic activity of Tel1 and its requirement for activation by the binding of MRX and DNA. Due to the high degree of structural conservation between ATM and the Tel1 FAT-KIN regions, where a large number of pathogenic mutations are located, our structure also provides a structural basis for many disease mutations found in ATM.Figure 1Structure of Tel1 Dimer(A) Overall structure of the nucleotide-bound (AMP-PNP) Tel1 dimer structure determined by cryo-EM to 3.9 Å resolution by Gold Standard Fourier shell correlation (GS-FSC). Regions of the structure are colored according to domains; kinase, red; C-FAT, pink; FLAP-BE, purple; N-FAT, blue; bridge, dark blue; C-HEAT, green; N-HEAT, light green. Approximate dimensions of the protein are also given.(B) Reconstruction of the FAT-KIN region determined to 3.7 Å resolution by GS-FSC, colored as in (A).(C) Domain arrangement of Tel1.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.Table 1Data Collection and Refinement Statistics**Data Acquisition**Dataset no.Dataset 1Dataset 2Dataset 3SampleTel1-AMP-PNPMicroscopeTitan KRIOS (eBIC, Oxfordshire, UK)Voltage (kV)300300300No. of micrographs4,5082,4455,656Nominal magnification75,000 (129,032)75,000 (129,032)75,000 (129,032)DetectorFalcon III (linear mode)Falcon III (linear mode)Falcon III (linear mode)Pixel size (A/pix)1.0851.0851.085Dose rate (e^−^/Å^2^/s)105120102Frames (e^−^/Å^2^/frame)23 (3.8)34 (2.6)34 (2.6)Total dose (e−/Å^2^)88.888.488.9Integration time (s)0.590.870.87Defocus range−1.1 to −3.2−1.1 to −3.2−1.2 to −3.2**Image Processing**ReconstructionTel1 dimer (EMD-10120)FAT-KIN (EMD-10120)SoftwareRELION-3.0RELION-3.0Particles167,596167,596Box size (pixels)380 × 380 × 380380 × 380 × 380SymmetryC2C2Map resolution (Å)3.93.7Map resolution range (Å)3.6--5.63.4--4.6Map sharpening B factor (Å^2^)−75−165**Coordinate Refinement**SoftwarePHENIXAlgorithmREAL SPACE REFINEMENTResolution (Å)4.03.7FSC~model\ vs.\ map~ = 0.5 (Å)4.13.9Correlation coefficient0.840.81**Model**PDB[6S8F](pdb:6S8F){#intref0095}No. of residues Protein5,158 (2,579 per monomer) Ligand (AMP-PNP)2 (1 per monomer)B factors overall243.7 (82.2 for FAT-KIN) Protein243.7 (82.2 for FAT-KIN) AMP-PNP223.3 (79.0 for FAT-KIN)Root-mean-square deviation Bond length (Å)0.006 Bond angle (°)0.99**Validation**MolProbity score1.86MolProbity clash score5.87Rotamer outliers (%)0.8C~β~ deviations (%)0Ramachandran plot (%) Favored90.4 Allowed9.5 Outliers0.1

Results and Discussion {#sec2}
======================

Structure of the Tel1 Dimer {#sec2.1}
---------------------------

Tel1 was expressed and purified as reported previously ([@bib34]), and its kinase activity shown to be stimulated synergistically by both dsDNA and MRX ([@bib16]). The overall Tel1 dimer structure was refined to a global resolution of 3.9 Å ([Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"} and [Table 1](#tbl1){ref-type="table"}). Using localized masking around density regions corresponding to the FAT-KIN domains as well as regions of HEAT repeats and/or signal subtractions to isolate the FAT-KIN domains improved the quality of the map to 3.7 Å for these regions, which correspond to two-thirds of the whole protein ([Figure S3](#mmc1){ref-type="supplementary-material"}). In key functional regions around the kinase domain and the dimer interface, the local resolution estimates are better than 3.5 Å; and densities for bulky side chains are clearly visible ([Figure S2](#mmc1){ref-type="supplementary-material"}). Consequently, we could build side chains into the majority of the FAT, kinase, and FATC domains (residues 1,527--2,787) and place confident sequence assignment between residues 968 and 1,526. The N-terminal HEAT repeats are flexible, as was also shown in ATM structures, and left as Cα trace only due to the lack of clear side-chain density. Our structure is in excellent agreement with that of an ATM closed dimer, which was limited to Cα-Cβ atoms ([@bib7]). Interestingly, we did not observe an open dimer conformation or monomers in our analysis ([Figure S2](#mmc1){ref-type="supplementary-material"}), although N-HEAT domains are mobile ([Figure S1](#mmc1){ref-type="supplementary-material"}).

Different subdomain terminologies have been used to describe PIKKs, including ATM. For simplicity, we use rigid bodies to define subdomains within the HEAT repeats and the FAT domain, which was originally assigned by multiple sequence alignments ([@bib8]). Specifically, by comparing the structure of Tel1 and those of ATM and mTOR, the N-terminal HEAT repeats can be separated into two rigid bodies, which we term N-HEAT (residues 1--1,162) and C-HEAT (residues 1,163--1,437) ([Figure 1](#fig1){ref-type="fig"}). There is a connecting region, denoted a bridge domain (residues 1,438--1,600) before the FAT domain, which we have extended and also divided into several rigid bodies: N-FAT (N-terminal FAT, 1,600--1,786), M-FAT (Middle-FAT, 1,787--2,128) and C-FAT (C-terminal FAT, 2,129--2,355) ([Figures 1](#fig1){ref-type="fig"} and [S3](#mmc1){ref-type="supplementary-material"}). The C-FAT consists of the FLAP-BE (as defined in [@bib7]) and HRD domain ([Figure 1](#fig1){ref-type="fig"}).

The Tel1 dimer interface is extensive and can be divided into three layers ([Figure 2](#fig2){ref-type="fig"}A); the top layer consists of PRD-I and LBE of one protomer interacting with a long helical antenna specific to Tel1^ATM^ called FLAP-BE, of the adjacent protomer (FLAP-BE′, where ' denotes elements from the adjacent protomer) ([Figure 2](#fig2){ref-type="fig"}); the middle layer mainly consists of FATC of one protomer and the adjacent M-FAT′ (immediately preceding FLAP-BE) of the other protomer, while the bottom layer consists of M-FAT-M-FAT′ interactions ([Figure 2](#fig2){ref-type="fig"}A). The buried surface area at the dimer interface is extensive, with over 3,000 Å^2^ per protomer. The bottom layer of the dimer interface is exclusively hydrophobic in nature, with a vast array of large bulky hydrophobic residues (Phe and Leu) forming a well-buried core around the 2-fold symmetry axis ([Figure 2](#fig2){ref-type="fig"}B). The middle layer employs a mixture of polar and hydrophobic residues ([Figure 2](#fig2){ref-type="fig"}C), whereas the upper layer, which has the smallest interface surface area and is the least well resolved, interacts via charge complementarity ([Figure 2](#fig2){ref-type="fig"}D). The hydrophobic nature of the bottom layer enables some conformational flexibility at the bottom layer of the dimer interface, whereas the top layer, which is polar in nature, can be broken or rearranged. Indeed, a relative rotation of the FAT-KIN regions in the ATM dimer has been observed in the open dimer conformation ([@bib7]).Figure 2Tel1 Dimer Interface(A) FAT-KIN dimer structure colored by domain as in [Figure 1](#fig1){ref-type="fig"}, and for clarity M-FAT′ is colored in pale yellow to distinguish it clearly. Different layers of the dimer interface are boxed and detailed views of the nature of the interface are shown in (B)--(D). See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Tel1 Nucleotide-Bound Kinase Domain Is in a Catalytically Productive Conformation {#sec2.2}
---------------------------------------------------------------------------------

Similar to the other PIKKs such as mTOR, ATM, DNA-PKc, and Mec1, the kinase domain is surrounded by the FAT domains that form a C-shaped cradle surrounding the kinase domain ([Figure 3](#fig3){ref-type="fig"}A). It is worth noting that N-FAT contacts the kinase C-lobe, whereas C-FAT contacts the N-lobe ([Figures 1](#fig1){ref-type="fig"}A and [3](#fig3){ref-type="fig"}A). M-FAT sits away from the kinase domain and instead contacts C-HEAT and is in close proximity with N-HEAT and could therefore transmit conformational changes from the HEAT region to the kinase domain ([Figures 1](#fig1){ref-type="fig"}A and [3](#fig3){ref-type="fig"}A).Figure 3Details of the Tel1 Kinase Domain and the PRD-I(A) Cryo-EM density of Tel1 FAT-KIN shows the FAT domains cradle the kinase domain. Domains are colored as in [Figure 1](#fig1){ref-type="fig"}.(B) Structural details of the AMP-PNP bound (with cryo-EM density shown as blue mesh) to the kinase domain (gray) with key structural features highlighted and labeled.(C) Molecular details of interacting residues with AMP-PNP, the activation loop (blue) and FATC (red) which support the catalytic loop (yellow).(D) Predicted peptide binding using superimposition of kinase-substrate peptide complex crystal structures of PKA, Pak-4, and Cdk2. The target serine/threonine is shown and labeled (P0) and the predicted location of the P+1 residue is highlighted and is close to Y2780 of the FATC.(E) Sequence alignment of the structurally conserved kα9 and kα10 and the intervening PRD of several PIKKs. An invariable tryptophan (W2702) that anchors the PRD is highlighted.See also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.

The structure of nucleotide-bound Tel1 shows the catalytic residues of the C-lobe in a catalytically productive conformation, with clear density for AMP-PNP ([Figures 3](#fig3){ref-type="fig"}B and 3C). The catalytic loop, containing the highly conserved ^2612^DRH^2614^ motif, adopts a similar conformation to that observed in mTOR structures ([Figures S2](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}) ([@bib45], [@bib46]), where D2612 is well-positioned to act as the catalytic base for deprotonation of the hydroxyl group from a bound peptide substrate. The side chains of H2614 and N2616, important for stabilizing transition state during phosphoryl transfer, co-ordinate the γ-phosphate of AMP-PNP ([Figures 3](#fig3){ref-type="fig"}B, 3C, [S2](#mmc1){ref-type="supplementary-material"}G, and S2H) ([@bib5]; [@bib53], [@bib45]). The Mg^2+^-binding N2617 of the catalytic loop, the ^2631^DLG^2633^ motif, and the adjacent activation loop are well-ordered, allowing us to model in one Mg^2+^ ion coordinating the β-/γ- (Mg1) of AMP-PNP into the density, using nucleotide-bound structures of protein kinase A (PKA), CDK2, and mTORC1 as a guide ([Figures 3](#fig3){ref-type="fig"}B, [S2](#mmc1){ref-type="supplementary-material"}G, and S2H) ([@bib12], [@bib45]). There is also weak density at the correct position for a second Mg^2+^, although studies on CDK2 suggest binding of the second "activating" Mg^2+^ is concomitant with substrate peptide binding ([@bib5]). Whether this is the case also for Tel1 is unclear and we have therefore omitted the second Mg^2+^ in our structural model. The activation loop, which is ordered in this kinase, wraps around the catalytic loop and supports kinase activity via several interactions. Most notably, residues E2646 and I2634 of the activation loop sandwich the catalytic loop, and there is an apparent interaction between R2613 of the catalytic loop (^2612^DRH^2614^ motif) and the main chain of the activation loop, close to the ^2631^DLG^2633^ motif. The catalytic loop is further constrained by two aromatic residues (W2783 and Y2787) from the C terminus of FATC ([Figure 3](#fig3){ref-type="fig"}C). These structural constraints explain the highly conserved nature of FATC and why mutations in this region abolish Tel1^ATM^ activity ([@bib19]).

The binding pocket for the adenosine ring of AMP-PNP is formed by a number of hydrophobic residues from both N- and C-lobes of the Tel1 kinase domain, with the Gly-rich loop from the N-lobe forming a partial lid over the bound nucleotide ([Figures 3](#fig3){ref-type="fig"}B and 3C). The conserved K2465 from the N-lobe contributes to α-/β-phosphate coordination of the bound AMP-PNP and is equivalent to K72 of PKA, which is essential for catalysis ([@bib18]) ([Figure 3](#fig3){ref-type="fig"}B). Interestingly, comparison of the Tel1 active site with nucleotide-bound mTOR in non-activated and RHEB-activated states ([@bib46]) shows that the N-lobe and the Gly-rich loop of Tel1 most closely resemble that of non-activated mTOR ([Figure S5](#mmc1){ref-type="supplementary-material"}). Further closure of the mTOR N-lobe and Gly-rich loop occur upon activation. Therefore, it is likely that the N-lobe and Gly-rich loop of Tel1 will also undergo further closure as part of the catalytic cycle. In addition to the Gly-rich loop, the active site is further surrounded by LBE, PRD, and FLAP-BE′ ([Figure 3](#fig3){ref-type="fig"}), highlighting the importance of these elements in regulating active site access.

Tel1^ATM^ PRD-I and FATC Regulate Substrate Binding {#sec2.3}
---------------------------------------------------

In addition to the open N-lobe, our structure shows that the active site cleft of the Tel1 kinase domain is restricted by the PRD, which we have denoted as the PRD-I (see below, [Figure 3](#fig3){ref-type="fig"}B). The PRD is a PIKK-specific feature that was originally identified in ATR as an element between the kinase domain and the FATC that is essential for the binding of the activator TopBP1 ([@bib28]). Subsequent PIKK structures have revealed that the regions proposed to be involved in TopBP1 binding are in the highly conserved Kα10 helix, whereas the regions between Kα9 and Kα10 are variable in length and composition between different PIKKs ([Figure 3](#fig3){ref-type="fig"}E). Therefore, we denote this variable region as the PRD-I, which is equivalent to Kα9b, Kα9c, and Kα9d identified in mTOR and ATM structures ([@bib7], [@bib45], [@bib46]).

In the nucleotide-free Tel1 and ATM symmetric dimer structures, the PRD-I, although only partly resolved, is predicted to occupy the position of a peptide substrate ([@bib7], [@bib44]). In the nucleotide-bound Tel1 structure, the complete PRD-I could be resolved. It structurally connects Kα9-Kα10 at the back of the kinase domain to the LBE and FATC at the front of the kinase domain ([Figure 3](#fig3){ref-type="fig"}B). Starting from Kα9, the PRD-I displays an extended loop followed by a single α helix, situated directly above the activation loop, reaching toward LBE and FLAP-BE′ before returning to Kα10 via a loop ([Figure 3](#fig3){ref-type="fig"}B). Importantly, PRD-I interacts with many of the key functional and structural elements, including the activation loop, the FATC, the LBE, and the FLAP-BE′ ([Figures 3](#fig3){ref-type="fig"}B and 3D). At its N terminus, an invariant W2702 of PRD-I inserts into the hydrophobic pocket between Kα9 and Kα10 ([Figure 3](#fig3){ref-type="fig"}B). Toward the C-terminal end, acidic residues in PRD-I (^2715^EEEHE^2719^) are in close proximity to a positively charged patch in FLAP-BE′ (^2197^KRHYHR^2202^) ([Figure 2](#fig2){ref-type="fig"}D). Together these elements occlude the access to the active site of Tel1.

To estimate the path of a bound Tel1 peptide substrate, we aligned the Tel1 kinase domain with the catalytic and activation loops of substrate-bound structures of PKA (PDB: [3x2u](pdb:3x2u){#intref0010}; [@bib12]), Cdk2 (PDB: [3qhw](pdb:3qhw){#intref0015}; [@bib5]), and Pak-4 (PDB: [4jdh](pdb:4jdh){#intref0020}; [@bib9]) ([Figure 3](#fig3){ref-type="fig"}D). It is clear that PRD-I in Tel1 overlaps with the peptide substrate binding site, whereas the γ-phosphate of AMP-PNP and the catalytic aspartate (D2612) are suitably close to the predicted location of the target Ser/Thr (P0) for phosphoryl transfer to occur ([@bib12]) ([Figure 3](#fig3){ref-type="fig"}D). The PRD-I, together with the LBE and FLAP-BE′, thus occludes the active site and occupies the substrate binding site. Therefore, it is a major determinant for inhibition and the requirement of Tel1 activation by MRX-dsDNA. Furthermore, Y2780 within the FATC sits close to the predicted P+1 peptide substrate position, suggesting a potential role in determining substrate specificity. This is consistent with a Y2780A mutant Tel1 demonstrating significantly defective levels of Rad53 phosphorylation, supporting the idea that this part of FATC may be involved in target recognition ([@bib29]). Thus, we suggest a dual role for FATC, being important for constraining the catalytic loop conformation as well as substrate peptide recognition.

Proposed Activation Mechanism of Tel1^ATM^ {#sec2.4}
------------------------------------------

Among the PIKK enzymes, only mTOR has a set of high-resolution structures of both non-active and activated states. Comparisons of mTORC1 and the activator-bound mTORC1-RHEB complex reveal that RHEB binding induces allosteric conformational changes to C-FAT that, via a clockwise rotation around the kinase C-lobe, results in the closure of the N-lobe and glycine-rich loop, thus realigning the active site ([@bib46]). RHEB binds at a significant distance away from the kinase domain, close to N-FAT ([@bib46]). Upon binding of RHEB, through HEAT domain relocation, significant conformational changes occur in M-FAT and are subsequently transmitted to C-FAT ([@bib46]). DNA-PKcs also bind to its activator, Ku70-Ku80-DNA, through its HEAT repeats. Structural comparisons between mTOR and DNA-PKcs alone and in complex with their activators reveal a common mode of allosteric activation involving domain movement of M-FAT and C-FAT ([@bib35], [@bib36], [@bib47]). Despite the structural and sequence divergence of the N-HEAT region, the FAT-KIN domains of PIKKs are highly conserved in their structures ([Figure S5](#mmc1){ref-type="supplementary-material"}). Furthermore, the conserved conformational changes in mTOR and DNA-PKc, irrespective of their distinct activator binding sites, suggest similar conformational changes might occur in Tel1 as a means for activation.

Tel1^ATM^ interacts with MRX/N via direct associations with the complex ([@bib23]), and recent studies suggest that each of the three MRX subunits binds Tel1, suggesting an extensive MRX-Tel1 interaction interface ([@bib16]). The interaction between Tel1 and the C terminus of Xrs2/Nbs1 has been mapped to regions in the N-HEAT and C-HEAT domains in Tel1^ATM^ ([@bib48]) in a similar location to DNA-PK and mTORC1 activator binding sites ([Figure S5](#mmc1){ref-type="supplementary-material"}). When we align the Tel1 and the inactive mTORC1 structures on their kinase C-lobes, N-FAT, and C-FAT align reasonably well, with the largest differences in M-FAT ([Figure S5](#mmc1){ref-type="supplementary-material"}). Therefore, it is plausible that binding of MRN/X would result in a concerted motion of HEAT and M-FAT, which is propagated to C-FAT, resulting in the N-lobe and glycine-rich loop closure analogous to RHEB-activated mTORC1 ([@bib46]). Distinct from mTOR, these movements would involve FLAP-BE within the C-FAT, which subsequently could affect PRD-I conformation and the dimer interface, presumably releasing inhibition for substrate binding and active site access.

In the apo-ATM and apo-Tel1 structures, both symmetric and asymmetric dimers were observed, with the ATM study suggesting that asymmetry is coupled with an increased basal activity *in vitro*. A recent study on apo-ATM also presents the existence of ATM monomers in their samples, which are also more active, although it is unclear if these monomers resulted directly from activation ([@bib54]). Indeed, given the characteristics of the Tel1 dimer interface observed in this study, it seems that a dimer-to-monomer transition would be energetically unfavorable with a free energy of dissociation (ΔG^Diss^) of ∼37 kcal/mol calculated in PISA ([@bib21]). Asymmetric dimers for ATM and Tel1 have been associated with disordered PRD-I ([@bib44]) and are proposed to be the active form or en-route to becoming active. If so, the activators\' roles would be either to stabilize the asymmetric dimers or to induce the asymmetric dimers. This is not inconsistent with the proposed allosteric activation mechanism upon activator binding, which could induce or stabilize the asymmetric arrangement. However, our studies do not provide evidence for the existence of a substantially asymmetric arrangement within the FAT-KIN domains when Tel1 is bound to Mg-AMP-PNP. Furthermore, we did not observe similar PRD-I disorder when Tel1 is nucleotide bound, and this is consistent with the low-level *in vitro* kinase activity of Tel1 in the absence of activators (∼0.065 phosphates transferred per minute per protomer) ([@bib16]). Activator-bound structures are required in order to understand how these kinases are activated.

Structural Basis for Hyperactive Mutations of Tel1 and Disease-Associated Mutants in ATM {#sec2.5}
----------------------------------------------------------------------------------------

The role of PRD-I in inhibiting the activity of Tel1 and a proposed allosteric activation mechanism are supported by Tel1 hyperactive mutations identified in a genetic screen to rescue Mec1-deficient cells ([@bib4]). Many mutations are in similar positions to cancer-associated mTOR hyperactivating mutations known to increase sensitivity to allosteric activation ([@bib46]). Several mutations map onto Kα9 and Kα10 and surrounding regions ([Figure 4](#fig4){ref-type="fig"}A). Among the mutant strains, three possess only single-amino acid substitutions (N2692D, F2576V, and Q2764H), that hyperactivate Tel1 activity. In one such mutant, N2692 of Kα9 is next to G2252 of C-FAT, which is also mutated in one of the strains, and therefore N2692D or G2252C could affect Kα9 conformation and consequently affect the PRD-I position ([Figure 4](#fig4){ref-type="fig"}B). Q2764 is within the FATC and also located at the dimer interface with M-FAT′, specifically in a region just before the FLAP-BE′. A Q2672H substitution could affect FLAP-BE′ to aid the relocation of PRD-I. There are also a number of mutations at the interface between N-FAT and C-lobe, close to the LBE and activation loop. These mutations could also affect substrate access ([Figure 4](#fig4){ref-type="fig"}A). Several mutations, e.g., I2336T and A2287V, are found within the C-FAT, close to the N-lobe and are similar to known mTOR hyperactivating mutations ([@bib46]). Presumably these mutations could allow the N-lobe to move closer to the active site in the absence of activator proteins.Figure 4Mapping of Tel1 Hyperactivating and ATM Disease-Associated Mutations(A) Tel1 FAT-KIN protomer is shown colored as in [Figure 1](#fig1){ref-type="fig"} with hyperactivating mutations found in [@bib4] mapped and shown as green spheres.(B) Molecular details of a cluster of mutations in kα9 found in cancer and described in hyperactivating Tel1 phenotypes.(C) Cancer-associated (dark gray spheres) and ataxia-telangiectasia-associated (A-T, purple spheres) mutations at structurally equivalent locations (see [Table S1](#mmc1){ref-type="supplementary-material"} for details).(D) Molecular details of G2609 (G2867 in ATM), which is mutated to arginine in A-T. See also [Table S1](#mmc1){ref-type="supplementary-material"}.

The high structural homology between Tel1 and ATM FAT-KIN regions allows us to map pathogenic A-T missense and cancer-associated mutations onto the structure ([Figure 4](#fig4){ref-type="fig"}C). A-T is caused by biallelic mutation of the *ATM* gene and a significant proportion of ATMs result in abolished ATM expression, via truncation, incorrect splicing, or incorrect frame-shifts ([@bib27], [@bib33], [@bib38]), suggesting that the molecular basis of A-T is loss of ATM protein. The majority of A-T missense mutations are found within the FAT-KIN domains ([@bib11]) and ATM is often mutated in multiple cancers, with the FAT-KIN regions exhibiting some of the highest mutational frequency ([@bib15], [@bib27]). Consistent with loss of activity in A-T and possibly in some cancers, some of the cancer-associated mutations are present in the highly conserved Gly-rich loop, the catalytic loop, as well as the activation loop, thus affecting catalytic activity directly. A good example is the ATM G2867R (G2609 in Tel1), which sits within the catalytic loop at a sharp turn just below the activation loop ([Figure 4](#fig4){ref-type="fig"}D). The introduction of a large charged side chain would certainly alter the structure of these elements critical for catalysis.

A large number of disease-associated substitutions are found outside the kinase active site and are distributed within the FAT domain and kinase-FAT interface. Strikingly, there is a large cluster of mutations within the FLAP-BE and others around PRD-I, especially in Kα9 and Kα10 and regions surrounding them ([Figure 4](#fig4){ref-type="fig"}; [Table S1](#mmc1){ref-type="supplementary-material"}). Presumably these mutations affect PRD-I, and thus substrate phosphorylation. The ATM, V2424G (L2179 in Tel1), sits close to the cancer-associated mutations E2423, R2443Q, E2444K, and D2448Φ (A2178, Q2206, R2209, and D2210 in Tel1, respectively) ([Figure 4](#fig4){ref-type="fig"}C; [Table S1](#mmc1){ref-type="supplementary-material"}) and are likely to disrupt the FLAP-BE structure as they hold the two helices together through salt bridges or hydrophobic interactions. Disrupting the FLAP-BE would likely alter the PRD-I within the context of a dimer and would therefore alter peptide substrate access. Another cluster of mutations exists around LBE and FATC. Mutations in these regions would also affect substrate access by affecting PRD-I. Interestingly, similar to hyperactive mutations, several pathogenic mutations are concentrated around the interfaces between the C-lobe and N-FAT; again these mutations could affect key elements including LBE and the activation loop or prevent allosteric activation.

The nucleotide-bound structure presented here reveals that Tel1 exists as an auto-inhibited dimer that is likely activated via an allosteric mechanism found in other PIKKs. With the exception of the N-lobe, the nucleotide coordinating residues and the catalytic site in the C-lobe are positioned or only require subtle rearrangement to allow catalysis. However, the PRD-I competes with peptide-substrates and occludes the access to the active site, and is likely the major determinant of the low basal activity of Tel1. The PRD-I is held in place by a number of PIKK-specific features, with mutations in these regions leading to altered activity and disease phenotypes. The movement of the PRD-I is clearly necessary for full kinase activity and based on other related PIKKs may occur through an allosteric mechanism that is common to this family of kinases. Hyperactivating mutations and disease-associated mutations of Tel1 and ATM clearly suggest the FAT domain is involved in regulating the activity of this kinase. Further structural work on an activator-bound Tel1^ATM^ is required to resolve how the PRD-I is evicted from the active site to allow peptide substrate binding.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Chemicals, Peptides, and Recombinant Proteins**Tel1 (expressed in *Saccharomyces cerevisiae*)([@bib16])N/AAdenylyl-imidodiphosphate (AMP-PNP Lithium salt)MerckCat \#10102547001**Deposited Data**Tel1-AMPPNP complex coordinatesThis workPDB:[6S8F](pdb:6S8F){#intref0025}Tel1-AMPPNP complex reconstructionThis workEMD-10120Tel1 reconstruction (initial model)([@bib34])EMD-4097ATM([@bib7])PDB:[5NP0](pdb:5NP0){#intref0030}mTORC1-RHEB complex([@bib46])PDB:[6BCU](pdb:6BCU){#intref0035}mTOR Kinase([@bib45])PDB:[4JSV](pdb:4JSV){#intref0040}Protein Kinase A (PKA)([@bib12])PDB:[3X2U](pdb:3X2U){#intref0045}Cdk2([@bib5])PDB:[3QHW](pdb:3QHW){#intref0050}Mec1-Ddc2([@bib43])PDB:[5X6O](pdb:5X6O){#intref0055}DNA-PKcs([@bib36])PDB:[5LUQ](pdb:5LUQ){#intref0060}**Experimental Models: Organisms/Strains***Saccharomyces cerevisiae:* strain background: PY265([@bib16])N/A**Recombinant DNA**pBL602 (GST-Tel1 under Gal promoter)([@bib34])N/A**Software and Algorithms**RELION-3.0([@bib51])N/AChimera([@bib31])N/AMotionCor2([@bib50])N/ACoot([@bib13])N/APhenix real space refine([@bib2])N/AGctf([@bib49])N/AGautomatch<https://www.mrc-lmb.cam.ac.uk/kzhang/>N/ALAFTER([@bib32])N/AGraphpad Prism 8N/AN/APROMALS3D([@bib30])N/APISA([@bib21])N/APyMOLSchrodinger, LLC, NY, USAN/AClustal Omega([@bib37])N/AMOLPROBITY([@bib10])N/A**Other**EM Grids (Lacey Formvar/Carbon, 300 mesh, Au)Ted PellaCat \#0182G

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for resources and reagents should be directed to and fulfilled by the Lead Contact, Xiaodong Zhang (<xiaodong.zhang@imperial.ac.uk>).

Method Details {#sec4.3}
--------------

### Electron Microscopy Grid Preparation {#sec4.3.1}

A frozen aliquot of *Saccharomyces cerevisiae* Tel1 (800nM, stored in 40mM HEPES 7.8, 10% Glycerol, 200mM NaCl, 2mM DTT, 0.1% Tween-20, 0.01% NP40, 1mM EDTA, 0.5mM EGTA) was diluted 8-fold using sequential addition of 10 μl volumes of buffer (50mM Tris-HCl, 50mM NaCl, pH 7.4 supplemented with AMP-PNP and Magnesium Acetate), and was incubated for 30 minutes on ice. The final concentration of Tel1 was 100nM; 1mM AMP-PNP; 4mM Mg(OAc)~2~. Samples (4 μl) were deposited onto Lacey Carbon 300 mesh gold grids that also have an additional ultrathin carbon support layer (Ted Pella Inc. USA), which were plasma-cleaned, for 30 seconds in air, prior to sample application. Samples were vitrified in liquid ethane at liquid nitrogen temperature using a Vitrobot Mk IV (FEI) set with a blotting force of -6, a waiting time of 60 s and a blotting time of 2 seconds. Plunge freezing was performed at 4°C and 100% humidity.

### CryoEM Data Acquisition {#sec4.3.2}

High-resolution data were collected for Tel1 over three sessions at eBIC (Oxfordshire, UK) on an FEI Titan KRIOS (Thermo Fisher) and are summarised in [Table 1](#tbl1){ref-type="table"}. For all three datasets, the microscopes were operated at 300kV with the specimen at cryogenic temperatures (approximately -180°C) with images recorded at 1-3 μm underfocus on a Falcon III direct electron detector in linear mode at a nominal magnification of 75,000 X, corresponding to a calibrated pixel size of 1.09 Å, and a cumulative total electron dose of ∼90 e^-^/Å^2^. We collected a total of 12,609 micrographs, which were fractionated into frames (dataset 1, 4508, 23 frames; dataset 2; 2445, 34 frames; dataset 3; 5656, 34 frames). A representative micrograph is shown in [Figure S1](#mmc1){ref-type="supplementary-material"}A.

### CryoEM Image Processing {#sec4.3.3}

Movie frames were aligned, corrected for drift, beam induced motion and dose-weighted using MotionCor2 ([@bib50]) using a 5 x 5 patch implemented in RELION-3.0 ([@bib51]). Contrast transfer function (CTF) fitting was performed using Gctf ([@bib49]). Particles were picked with Gautomatch using re-projections of a low resolution Tel1 EM structure ([@bib34]) for selection. Particles were extracted in RELION-3.0 using a box size of 400 x 400 pixels and binned four times for initial processing. The number of particles picked per dataset are summarised in [Table 1](#tbl1){ref-type="table"}. Reference-free 2D classification of particles from a single dataset was performed in RELION-3.0 and revealed two major views ([Figure S1](#mmc1){ref-type="supplementary-material"}A) and subsequent 3D volumes after refinement showed preferential orientation issues. Therefore, 2D classification was omitted as a first step and 3D classification with an initial Tel1 model ([@bib34]), filtered to 60 Å, was performed instead for all datasets. Particle star files were sub-divided to speed up the processing pipeline, as the datasets still contained non-particles and 'junk' not removed by 2D classification. Initial 3D classification with 4 classes produced a single class (23% particles) that exhibited features expected for this protein. Similar 3D classes from each batch/dataset were selected, re-extracted twice binned, and joined before an initial consensus 3D refinement, which converged to 5.8 Å. After 3D refinement the particle stack was further cleaned using 3D classification in RELION-3.0 using local angular searches, higher T-factors (T=8) and sub-dividing into six classes. Of the 6 classes many displayed over-fitted and noisy features, however two classes (29%, and ∼10%, ∼160K and ∼54K particles) showed clear secondary structure and internal features and were selected for further refinement. Particles corresponding to the best 3D classes were re-extracted (1.085 Å/pixel) in a slightly smaller box size (380 x 380 pixels) and were refined according to the gold-standard refinement procedure implemented in RELION-3.0 applying C2 symmetry and using a soft mask (C2 symmetric) corresponding to the protein. Beam-induced particle polishing ([@bib52]) followed by CTF refinement ([@bib51]) improved the map resolution producing a final map of the Tel1 dimer at 3.9 Å (class 01) and 6.0 Å (class03) according to the FSC = 0.143 criterion. Local resolution estimates calculated in RELION-3.0 showed that density regions corresponding to the N-terminal HEAT repeats were of lower resolution (∼5 Å) as compared to the kinase-containing C-terminal half (∼3.6 -- 4.4 Å, [Figure S2](#mmc1){ref-type="supplementary-material"}A). Using a soft mask (C2 symmetrized) encompassing some of the HEAT repeat regions, the FAT domain and the C-terminal kinase domain of the dimer, 3D refinement (gold-standard) improved the resolution yielding a 3.7 Å reconstruction after post-processing (according to FSC = 0.143 criterion) for Class01 and 4.7 Å after post-processing (according to FSC = 0.143 criterion) for Class03, corresponding to approximately two thirds of the protein. Angular accuracy and angular distribution plots suggest that rare views were captured by omitting initial 2D classification steps and that the early preferential orientation issues were circumvented as confirmed by directional FSC plots ([@bib40]), demonstrating a reasonably isotropic reconstruction. An improved quality map corresponding to the kinase core was produced using signal subtraction in RELION-3.0, masking the HEAT repeat regions and refined (gold standard) masking the remaining kinase-M-FAT regions. This reconstruction was assessed to be 3.7 Å after post-processing (according to FSC = 0.143 criterion). Local resolution estimates show that the best resolution regions are better than 3.5 Å and the map shows defined secondary structure features and clearly resolved bulky side chains ([Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}). A set of 167596 particles images (∼47% from dataset 1, ∼12% from dataset 2, ∼41% from dataset 3) were used for the final reconstructions.

### Model Building and Refinement {#sec4.3.4}

The final 3.7 Å and 3.9 Å EM maps were sharpened with a negative B-factor of -200, as determined by RELION-3.0, or less to avoid high-resolution noise and therefore over fitting of a model. A structure of dimeric human ATM (pdb [5np0](pdb:5np0){#intref0075}) was docked into the maps in the first instance. It was clear from this initial fitting that AMP-PNP was bound in the active site. The ATM model, which is restricted to Cα-Cβ only, was manually fitted as rigid body regions into our maps and residues that did not fit the density or that clearly differed between species were trimmed in Coot ([@bib13]). The high-resolution maps permitted accurate model building and therefore we built the structure manually starting with the kinase bound to AMP-PNP using the high-resolution nucleotide-bound X-ray structures of mTOR ([@bib45]) and PKA ([@bib12]) as guides alongside side-chain density in our maps to model the correct location of the catalytic loop, activation loop and the glycine-rich loop. The kinase domain was subsequently built manually by using residues at the AMP-PNP bound active site as a start point and using bulky side chains as landmarks for correct sequence assignment against UNIPROT accession code [P38110](uniprotkb:P38110){#intref0080}. We also made use of a local agreement filtering program (Local Agreement Filtering Algorithm for Transmission EM Reconstructions \[LAFTER\]) ([@bib32]) that produces a map filtered to maintain consistent features between the two independent half-maps from gold-standard refinement and recovers more signal. This allowed us to confidently place residues in loops and regions where sharpening did not aid model building. We were able to build co-ordinates with the majority of side chains corresponding to residues 1527-2787 and place residues with sequence assignment (but occasional side chains) to 967-1526. The N-HEATs were more challenging to build and so these were built as a poly-Alanine trace. The co-ordinates for the model corresponding to the FAT-Kinase regions of the dimer were first real space refined in PHENIX ([@bib1], [@bib2]) against the 3.7 Å map (sharpened with a B-factor of -165 Å^2^ for the FATKIN and -200 Å^2^ for the kinase core). The Tel1 Dimer co-ordinates (which include the previously refined FAT-Kinase region) were refined against the 3.9 Å map (sharpened with -75 B-factor). In both cases data used in refinement was limited to spatial frequencies estimated by RELION to prevent over-fitting. Ramachandran, C~β~, non-crystallographic symmetry (NCS), and secondary structure restraints (generated in PHENIX using caBLAM) were used throughout the refinement to ensure good model geometry and the coordinates were validated using MOLPROBITY ([@bib10]) in PHENIX. Typically 3-cycles of real space refinement were run (3 macro cycles of global and local optimization and B-factor refinement), with PHENIX automatically estimating relative weighting of the restraints and map to prevent over-fitting ([@bib2]). Refinement and model statistics are given in [Table 1](#tbl1){ref-type="table"}. Map vs model FSC curves were also generated in PHENIX as part of the refinement procedure and given in [Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}.

### Model Interpretation and Analysis {#sec4.3.5}

Figures were created using PyMOL (Schrodinger, LLC) and UCSF Chimera ([@bib31]). Structural superposition of structures was performed in PyMOL aligning kinases by their C-lobes. Dimer interface buried surface area estimates were calculated using PISA ([@bib21]). Multiple sequence alignments were performed using Clustal Omega ([@bib37]) and displayed in Jalview. Structure-based sequence alignments were performed in PROMALS3D ([@bib30]).

Quantification and Statistical Analysis {#sec4.4}
---------------------------------------

CryoEM data were analysed and quantified using a Bayesian approach as described in RELION-3.0 ([@bib51]). No statistical methods were used to predetermine sample size except sufficient images were collected to ensure adequate reconstructions could be obtained.

Data and Code Availability {#sec4.5}
--------------------------

The cryoEM reconstructions and atomic co-ordinates generated in this study are available at the EMDB under accession code EMD-10120 and the RCSB under the PDB code [6S8F](pdb:6S8F){#intref0085}.
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